Target Price | CHF770.50 |
Price | CHF821.40 |
Deviation | 6.20% |
Number of Estimates | 14 |
14 Analysts have issued a price target Swiss Life 2026 . The average Swiss Life target price is CHF770.50. This is 6.20% lower than the current stock price. The highest price target is CHF900.00 9.57% , the lowest is CHF575.00 30.00% . | |
A rating was issued by 16 analysts: 6 Analysts recommend Swiss Life to buy, 7 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Swiss Life stock has an average upside potential 2026 of 6.20% . Most analysts recommend the Swiss Life stock at Hold. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 10.92 | 18.42 |
16.63% | 68.79% | |
Net Margin | 11.12% | 7.01% |
34.46% | 36.97% |
5 Analysts have issued a sales forecast Swiss Life 2025 . The average Swiss Life sales estimate is CHF18.4b . This is 68.79% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.2b 94.26% , the lowest is CHF8.9b 18.10% .
This results in the following potential growth metrics:
2024 | CHF10.9b | 16.63% |
---|---|---|
2025 | CHF18.4b | 68.79% |
2026 | CHF18.8b | 2.20% |
2027 | CHF18.3b | 2.65% |
2028 | CHF22.4b | 22.41% |
9 Swiss Life Analysts have issued a net profit forecast 2025. The average Swiss Life net profit estimate is CHF1.3b . This is 6.37% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.4b 11.58% , the lowest is CHF1.2b 1.82% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.2b | 12.10% |
---|---|---|
2025 | CHF1.3b | 6.37% |
2026 | CHF1.4b | 6.91% |
2027 | CHF1.5b | 5.98% |
2028 | CHF1.6b | 9.38% |
2024 | 11.12% | 34.46% |
---|---|---|
2025 | 7.01% | 36.97% |
2026 | 7.33% | 4.56% |
2027 | 7.98% | 8.87% |
2028 | 7.13% | 10.65% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 42.29 | 45.26 |
14.27% | 7.02% | |
P/E | 18.15 | |
EV/Sales | 1.77 |
9 Analysts have issued a Swiss Life forecast for earnings per share. The average Swiss Life EPS is CHF45.26 . This is 8.33% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF47.48 13.64% , the lowest is CHF43.33 3.71% .
This results in the following potential growth metrics and future valuations:
2024 | CHF42.29 | 14.27% |
---|---|---|
2025 | CHF45.26 | 7.02% |
2026 | CHF48.39 | 6.92% |
2027 | CHF51.28 | 5.97% |
2028 | CHF56.09 | 9.38% |
Current | 19.66 | 16.88% |
---|---|---|
2025 | 18.15 | 7.68% |
2026 | 16.98 | 6.45% |
2027 | 16.02 | 5.65% |
2028 | 14.64 | 8.61% |
Based on analysts' sales estimates for 2025, the Swiss Life stock is valued at an EV/Sales of 1.77 and an P/S ratio of 1.26 .
This results in the following potential growth metrics and future valuations:
Current | 2.99 | 69.89% |
---|---|---|
2025 | 1.77 | 40.68% |
2026 | 1.74 | 2.15% |
2027 | 1.78 | 2.71% |
2028 | 1.46 | 18.30% |
Current | 2.13 | 49.91% |
---|---|---|
2025 | 1.26 | 40.75% |
2026 | 1.24 | 2.15% |
2027 | 1.27 | 2.72% |
2028 | 1.04 | 18.31% |
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Feb 05 2025 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Dec 12 2024 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Dec 08 2024 |
HSBC |
Hold
➜
Hold
|
Unchanged | Nov 24 2024 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Mar 31 2025 |
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Feb 05 2025 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Dec 12 2024 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Dec 08 2024 |
Unchanged
HSBC:
Hold
➜
Hold
|
Nov 24 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.